The role of clopidogrel resistance-related genetic and epigenetic factors in major adverse cardiovascular events among patients with acute coronary syndrome after percutaneous coronary intervention

The role of clopidogrel resistance-related genetic and epigenetic factors in major adverse cardiovascular events among patients with acute coronary syndrome after percutaneous coronary intervention

Despite patients with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI) and receiving clopidogrel therapy, some patients still experience major adverse cardiovascular events (MACEs). Clopidogrel resistance, which may be regulated by genetic and epigenetic factors, may...

Full description

Bibliographic Details
Main Authors: Astuti Giantini, Ina S. Timan, Rahajuningsih Dharma, Renan Sukmawan, Rianto Setiabudy, Idrus Alwi, Alida R. Harahap, Erlin Listiyaningsih, Lia G. Partakusuma, Arif R. Tansir, Windy Sahar, Rakhmad Hidayat
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-02-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
acute coronary syndrome
clopidogrel resistance
epigenetic factor
genetic factor
major adverse cardiovascular events
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2022.1027892/full

Internet

https://www.frontiersin.org/articles/10.3389/fcvm.2022.1027892/full

Similar Items